- Sun Life US announced the launch of its new Expert Cancer Review service, designed to support members facing a cancer diagnosis with access to an objective, documented second opinion from an independent oncology specialist
- Beginning July 1, the service will be embedded in all new and renewing Sun Life (TSX:SLF) stop-loss plans, offering critical support at a time when cancer remains the most common and costly condition in the US healthcare system
- According to Sun Life’s annual high-cost claims report, malignant neoplasm diagnoses account for over 40 per cent of total claims spend, particularly affecting adults aged 40 to 59
- Sun Life stock (TSX:SLF) last traded at C$88.98
This content has been prepared in collaboration with Sun Life, a third-party issuer, and is intended for informational purposes only.
Sun Life US, the nation’s leading independent provider of medical stop-loss insurance, announced the launch of its new Expert Cancer Review service, designed to support members facing a cancer diagnosis with access to an objective, documented second opinion from an independent oncology specialist.
Beginning July 1, the service will be embedded in all new and renewing Sun Life (TSX:SLF) stop-loss plans, offering critical support at a time when cancer remains the most common and costly condition in the US healthcare system. According to Sun Life’s annual high-cost claims report, malignant neoplasm diagnoses account for over 40 per cent of total claims spend, particularly affecting adults aged 40 to 59.
The Expert Cancer Review service is powered by Health Navigator, Sun Life’s healthcare navigation and advocacy platform. Members are paired with one-on-one care advisors who coordinate with independent expert oncologists to review diagnoses and treatment plans. The resulting second opinions are delivered in plain language to both the member and their treating physician, helping ensure clarity and confidence in the care journey.
The need for such services is underscored by Sun Life’s 2023–2024 data, which revealed that 39 per cent of members who sought second opinions experienced a change in their diagnostic strategy, diagnosis, or treatment plan.
“As a former nurse, I recognize the profound impact a cancer diagnosis can have on people. By offering access to expert second opinions, we will be able to empower our members with knowledge and give them confidence in their cancer treatment plans,” Jennifer Collier, president, Health and Risk Solutions, Sun Life US said in a news release. “This new service reflects our commitment to helping members get the care they need, ensuring they are supported and well informed during a challenging time.”
As a stop-loss provider, Sun Life works to help employers who self-fund their employee health plans manage high-dollar claims. According to the Kaiser Family Foundation (KFF), 63 per cent of covered workers in the US are enrolled in self-funded plans, making services like Expert Cancer Review a valuable addition to employer-sponsored benefits.
Sun Life is an international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional clients.
Sun Life stock (TSX:SLF) last traded at C$88.98.
Join the discussion: Find out what everybody’s saying about this stock on the Sun Life Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.